Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018;14(1):5-8.
doi: 10.5114/aic.2018.74349. Epub 2018 Mar 22.

Pharmacological protection of reperfusion injury in ST-segment elevation myocardial infarction. Gone with the wind?

Elisabetta Tonet  1 , Davide Bernucci  1 , Giampaolo Morciano  2   3 , Gianluca Campo  1   3
Affiliations
Editorial

Pharmacological protection of reperfusion injury in ST-segment elevation myocardial infarction. Gone with the wind?

Elisabetta Tonet et al. Postepy Kardiol Interwencyjnej. 2018.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Infarct size and its reduction by timely reperfusion and prevention of reperfusion injury. Green: Myocardium salvaged by reperfusion. About half of the residual infarct size is due to reperfusion injury and it is preventable. Red: Myocardium salvaged by prevention of reperfusion injury. Benefits of timely reperfusion and prevention of reperfusion injury. Blue: Residual infarct size
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Morciano G, Giorgi C, Bonora M, et al. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. J Mol Cell Cardiol. 2015;78:142–53. - PubMed
    1. Engstrom T, Kelbaek H, Helqvist S, et al. Effect of ischemic post-conditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: a randomized clinical trial. JAMA Cardiol. 2017;2:490–7. - PMC - PubMed
    1. Mentias A, Mahmoud AN, Elgendy IY, et al. Ischemic post-conditioning during primary percutaneous coronary intervention: a meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2017;90:1059–67. - PubMed
    1. Inagaki F, Chen L, Ikeno F, et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation. 2003;108:2304–7. - PubMed
    1. Lincoff AM, Roe M, Aylward P, et al. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI randomized controlled trial. Eur Heart J. 2014;35:2516–23. - PubMed

Publication types

LinkOut - more resources